BRANFORD, Conn. / Nov 01, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in two upcoming investor conferences:
About the Canaccord Genuity MedTech Diagnostics and Digital Health & Services Forum
Quantum-Si management will attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum, taking place at the Westin NY Grand Central on Thursday, November 16, 2023.
Jeff Hawkins, Chief Executive Officer of Quantum-Si, will participate in a fireside chat on Thursday, November 16, at 4:30 – 4:55 p.m. Eastern Time.
About the 6th Annual Evercore ISI HealthCONx Conference
Quantum-Si management will attend the 6th Annual Evercore ISI HealthCONx Conference, taking place at the Kimpton Epic Hotel in Miami, Florida on November 28-30, 2023.
Jeff Hawkins will participate in a fireside chat on Wednesday, November 29, at 7:55 – 8:15 a.m. Eastern Time.
Where to View
A live and archived webcast of both events will be available in the “Investors” section of the Quantum-Si website under Events & Presentations.
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantum-si.com.
| Last Trade: | US$1.13 |
| Daily Change: | -0.02 -1.74 |
| Daily Volume: | 3,316,196 |
| Market Cap: | US$206.290M |
August 05, 2025 June 17, 2025 June 10, 2025 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
